These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 28585150
1. Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases. Sun D, Chen WH, Baralc S, Wang J, Liu ZS, Xia YP, Chen L. J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):433-438. PubMed ID: 28585150 [Abstract] [Full Text] [Related]
2. Mild Encephalitis/Encephalopathy with Reversible Splenial Lesion (MERS) due to Cytomegalovirus: Case Report and Review of the Literature. Feraco P, Porretti G, Marchiò G, Bellizzi M, Recla M. Neuropediatrics; 2018 Feb; 49(1):68-71. PubMed ID: 29179234 [Abstract] [Full Text] [Related]
8. [A Pediatric Case of Clinically Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion(MERS)with Recurrent TIA-like Symptoms over a Prolonged Period]. Shigeno A, Hiu T, Iwanaga H, Yasu T, Honda R, Nakaoka K, Fukuda Y, Ono T, Kawahara I, Haraguchi W, Ushijima R, Tsutsumi K. No Shinkei Geka; 2020 Feb; 48(2):131-140. PubMed ID: 32094312 [Abstract] [Full Text] [Related]
9. Mild encephalitis/encephalopathy with a reversible splenial lesion associated with systemic Mycoplasma pneumoniae infection in North America: a case report. Talukder NT, Feezel A, Lankford JE. J Med Case Rep; 2022 Feb 20; 16(1):74. PubMed ID: 35183255 [Abstract] [Full Text] [Related]
10. [Mild Encephalopathy with Reversible Splenial Lesion(MERS)]. Sato A. No Shinkei Geka; 2021 Mar 20; 49(2):413-417. PubMed ID: 33762466 [Abstract] [Full Text] [Related]
13. The first pediatric case of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) associated with Neisseria meningitidis. Ozenen GG, Sahbudak Bal Z, Ersayoglu I, Eraslan C, Aydemir S, Ozkinay F, Kurugol Z. Brain Dev; 2022 Feb 20; 44(2):184-188. PubMed ID: 34563415 [Abstract] [Full Text] [Related]
15. Statistical Analysis of the Apparent Diffusion Coefficient in Patients with Clinically Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Indicates That the Pathology Extends Well beyond the Visible Lesions. Qing Y, Xiong W, Da-Xiang H, Juan Z, Fei W, Yong-Qiang Y. Magn Reson Med Sci; 2020 Feb 10; 19(1):14-20. PubMed ID: 30956273 [Abstract] [Full Text] [Related]
17. [Mild encephalitis/encephalopathy with a reversible splenial corpus callosum lesion (MERS)]. Moreno-Caballero L, Navas-Campo R, Bello-Franco CM, Sesé-Lacámara L, Sáez-Valero E, Gimeno-Peribáñez MJ. Rev Neurol; 2021 Sep 01; 73(6):219-222. PubMed ID: 34515335 [Abstract] [Full Text] [Related]
18. Thyroid crisis mimicking clinically mild encephalitis/encephalopathy with a reversible splenial lesion: A pediatric case report. Matsubara K, Kuki I, Yamamoto N, Nagase S, Inoue T, Nukui M, Okazaki S, Yamada Y, Kawawaki H. Brain Dev; 2021 Apr 01; 43(4):596-600. PubMed ID: 33408037 [Abstract] [Full Text] [Related]
19. Reversible lesion in the splenium of the corpus callosum. Tetsuka S. Brain Behav; 2019 Nov 01; 9(11):e01440. PubMed ID: 31588684 [Abstract] [Full Text] [Related]
20. Cytomegalovirus-Associated Mild Encephalopathy/Encephalitis With Reversible Splenial Lesion. Fu ML, Han N, Wang W. Neurologist; 2021 Sep 07; 26(5):172-174. PubMed ID: 34491933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]